Esig, Narisa N.
HRN: 23-90-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/17/2023
10/17/2023
IV
4.5
Now Only
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes